New approach to ID chemicals that raise risk of breast cancer

June 3, 2015, University of California - Berkeley
Credit: Elena Zhukova

A study published today in Environmental Health Perspectives outlines a new method for assessing how synthetic chemicals and pollutants may contribute to breast cancer risk. In addition to developing the chemical testing approach, the authors identify two critical needs: the need for new chemical safety testing methods, and the need to screen more chemicals.

Inherited genes only explain about a quarter of a woman's risk of developing breast cancer. Exposure to and pollutants in air, water, food, workplaces and consumer products may account for a significant portion of breast cancer risk.

More than 34 million tons of synthetic chemicals are produced or imported into the U.S. every year, and hundreds of these chemicals are commonly found in women's blood, urine and breast tissue. While most have not been tested for their carcinogenic potential, among those that have, hundreds increase mammary tumors in laboratory animals. Animal tests, however, are both time- and resource-intensive, and they rarely evaluate the effects of during early life or prenatal development. To address these issues, a panel of experts developed a new method of identifying chemicals that may increase breast cancer risk. The results of their work were published today.

The scientists reached three important conclusions:

  1. Both genotoxicity (a 's ability to damage genetic information in a cell) and endocrine disruption (interfering with normal hormonal activity) are significant contributors to breast cancer potential, so any comprehensive chemical assessment must evaluate both categories of biological mechanisms.
  2. While useful test methods exist for evaluating chemicals' genotoxicity and estrogen-like activity, there are insufficient methods for testing chemical effects on other biological processes relevant to breast cancer, including progesterone activity.
  3. The researchers found large gaps in available test data even for chemicals generally thought of as well-tested.

"The basic question is, what would you need to know about a chemical to be able to say with confidence that it doesn't raise the risk of breast cancer?" said Megan Schwarzman, a physician and researcher at UC Berkeley and the lead author of the study.

The panel of scientists first identified biological processes that, when disturbed, could increase . They then determined what tests exist to assess whether chemicals interfere with those vulnerable . "These are pretty complex chains of causation," Schwarzman said, "so we tried to build a hazard assessment approach to recognize that complexity."

The panel concluded that new test methods are needed to effectively evaluate chemical risks. "Developing rapid, inexpensive chemical tests to fill the gaps identified in this study will make it easier for manufacturers to choose safer chemicals for ," said Ruthann Rudel, a toxicologist at Silent Spring Institute and a co-author of the study.

"There are so many places we can use this information today—regulators can consider requiring these recommended tests now; manufacturers can choose to use chemicals that pass these tests; and consumers can request that their suppliers use products that have undergone these tests. Meanwhile, we are funding research to fill the gaps that were identified." said Mhel Kavanaugh-Lynch, director of the California Breast Cancer Research Program, which funded this study.

"That's one of the reasons it's been such a great project," Schwarzman says of the study and CBCRP's response. "We're actively trying to use the results to change how chemicals are tested and the decisions that are made in public policy. We see the potential for chemical testing to contribute to prevention efforts."

Beyond contributing to the identification of breast carcinogens, the authors hope that the methods they developed can be applied to other diseases, such as other cancers or neurological disorders that may be affected by chemical exposure.

Explore further: Improve chemical testing on mammary glands to reduce risk of breast cancer

More information: The paper is available online: ehp.niehs.nih.gov/1408337/

Related Stories

Improve chemical testing on mammary glands to reduce risk of breast cancer

October 24, 2014
A new commentary by Center for Occupational and Environmental Health (COEH) researchers, published in Reproductive Toxicology, covers the emerging evidence that chemical exposure may contribute to breast cancer risk. It recommends ...

Scientists call for safety testing of chemicals to include prenatal exposures

June 22, 2011
A review published online June 22 ahead of print in the peer-reviewed journal Environmental Health Perspectives (EHP) reports the conclusions of an international workshop on ways to improve chemicals safety testing for effects ...

Importance of clinically actionable results in genetic panel testing for cancer

May 27, 2015
While advances in technology have made multigene testing, or "panel testing," for genetic mutations that increase the risk of breast or other cancers an option, authors of a review published today in the New England Journal ...

BPA stimulates growth of breast cancer cells, diminishes effect of treatment

June 23, 2014
Bisphenol A (BPA), a chemical commonly used in plastics, appears to increase the proliferation of breast cancer cells, according to Duke Medicine researchers presenting at an annual meeting of endocrine scientists.

Research on cancer blood test is overhyped in the media

April 23, 2015
Headlines today are heralding a new "simple blood test", claiming it can accurately predict if a woman will develop breast cancer in the future. This sounds amazing.

Recommended for you

Sequencing genomes of Nigerian women could help prevent many lethal breast cancers

August 21, 2018
For the first time, DNA contributed by Sub-Saharan African women has been thoroughly evaluated with innovative genomics technology in an effort to understand the genetic bases for breast cancer in African populations.

First in-depth profile of CAR T-cell signals suggests how to improve immunotherapy

August 21, 2018
CAR T-cell therapy, which reprograms immune cells to fight cancer, has shown great promise in people with some blood cancers who have not responded to other treatments. But until now, the underlying biological pathways enabling ...

Scientists take step toward new, targeted lung cancer treatment

August 21, 2018
Scientists have identified a key molecular player in a subtype of lung cancer which could lead to a new way to tackle the disease, according to research published in Nature Communications.

New compound advances into Phase 1 trial for pancreatic cancer

August 21, 2018
A compound discovered at Sanford Burnham Prebys Medical Discovery Institute (SBP) has advanced into a Phase 1 trial for metastatic pancreatic cancer. Called CEND-1 (scientifically known as iRGD), the compound was exclusively ...

Simple test could identify bladder cancer patients who won't respond to immunotherapy

August 21, 2018
Patients who are unlikely to benefit from a commonly used immunotherapy for bladder cancer could be identified by a simple blood test, according to researchers at Brighton and Sussex Medical School (BSMS).

Annual pap test a 'thing of the past?'

August 21, 2018
The United States Preventive Services Task Force (USPSTF) has released new recommendations on screening for cervical cancer. These latest recommendations continue the trend of decreasing participant burden by lengthening ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.